נגישות
menu      
Advanced Search
Syntax
Search...
Volcani treasures
About
Terms of use
Manage
Community:
אסיף מאגר המחקר החקלאי
Powered by ClearMash Solutions Ltd -
Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats
Year:
1983
Source of publication :
Hypertension
Authors :
Ezra, David
;
.
Volume :
5
Co-Authors:
Bayorh, M.A., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Zukowska-Grojec, Z., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Ezra, D., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Feuerstein, G.Z., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, USUHS, Bethesda, MD, United States
Kopin, I.J., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Facilitators :
From page:
172
To page:
179
(
Total pages:
8
)
Abstract:
In rats between the ages of 4 and 12 or 14 weeks, repeated daily subcutaneous administration of arachidonate (AA) at a dose of 50 or 200 mg/kg significantly retarded the development of hypertension in spontaneously hypertensive rats (SHR) but did not alter the normal age-related increase in blood pressures (BP) of normotensive (WKY) rats. Heart rates (HR) and plasma levels of norepinephrine (NE), but not epinephrine, were lower in AA-treated SHR than in saline-treated animals. AA-treated SHR and WKY gained less weight than the saline-treated controls. In pithed AAtreated SHR, stimulation of the sympathetic outflow (50 V, for 1 minute at 0.3 or 3.0 Hz) and intravenous administration of NE (0.3 or 3.0 g/kg) evoked smaller pressor responses than in salinetreated controls, but the stimulation-evoked increases in plasma catecholamines were unchanged by AA treatment. These results indicated that, in SHR, chronic AA treatment reduces BP by mechanisms that do not directly affect NE release from sympathetic nerves. There appears to be both reduced central nervous system activation of the sympathetic outflow and diminshed responses to peripheral sympathetic stimulation and exogeneous NE which may be secondary to the reduced vascular hypertrophy that usually accompanies the development of high BP in SHR.
Note:
Related Files :
animal experiment
Animals
cardiovascular system
heart rate
Hypertension
spontaneously hypertensive rat
Show More
Related Content
More details
DOI :
Article number:
Affiliations:
Database:
Scopus
Publication Type:
article
;
.
Language:
English
Editors' remarks:
ID:
30283
Last updated date:
02/03/2022 17:27
Creation date:
17/04/2018 00:53
Scientific Publication
Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats
5
Bayorh, M.A., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Zukowska-Grojec, Z., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Ezra, D., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Feuerstein, G.Z., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, USUHS, Bethesda, MD, United States
Kopin, I.J., Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, United States, Autonomic Research Unit, Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats
In rats between the ages of 4 and 12 or 14 weeks, repeated daily subcutaneous administration of arachidonate (AA) at a dose of 50 or 200 mg/kg significantly retarded the development of hypertension in spontaneously hypertensive rats (SHR) but did not alter the normal age-related increase in blood pressures (BP) of normotensive (WKY) rats. Heart rates (HR) and plasma levels of norepinephrine (NE), but not epinephrine, were lower in AA-treated SHR than in saline-treated animals. AA-treated SHR and WKY gained less weight than the saline-treated controls. In pithed AAtreated SHR, stimulation of the sympathetic outflow (50 V, for 1 minute at 0.3 or 3.0 Hz) and intravenous administration of NE (0.3 or 3.0 g/kg) evoked smaller pressor responses than in salinetreated controls, but the stimulation-evoked increases in plasma catecholamines were unchanged by AA treatment. These results indicated that, in SHR, chronic AA treatment reduces BP by mechanisms that do not directly affect NE release from sympathetic nerves. There appears to be both reduced central nervous system activation of the sympathetic outflow and diminshed responses to peripheral sympathetic stimulation and exogeneous NE which may be secondary to the reduced vascular hypertrophy that usually accompanies the development of high BP in SHR.
Scientific Publication
You may also be interested in